Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

Open Access 01-12-2020 | Human Immunodeficiency Virus | Research article

Cysteine-cysteine chemokine receptor 5 (CCR5) profile of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria

Authors: Ekerette Friday Ekere, Monday F. Useh, Henshaw Uchechi Okoroiwu, Tatfeng Youtchou Mirabeau

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

Cysteine-cysteine chemokine receptor 5 is the main HIV co-receptor involved in the virus and cell-to-cell spread. A variant of the CCR5 gene known as CCR5-Δ32 which is a product of 32 base pair deletion in the gene plays critical role in the infection and progression to AIDS. The study was carried out to determine the CCR5 genotype of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar.

Methods

A total of 100 subjects attending HIV clinic, University of Calabar Teaching Hospital were purposively recruited for this study. DNA was extracted from each sample using the Quick gDNA miniprep DNA extraction kit, Zymo Research. Polymerase chain reaction (PCR) was used in the amplification of CCR5 gene in each DNA in a 9700 ABI Thermo cycler and then resolved on 4% agarose gel electrophoresis.

Result

Out of the 100 samples assessed, 100 (100%) were homozygous for the CCR5 wild type gene (CCR5-wt), while none (0%) was homozygous for the CCR5-Δ32 (mutant type), and heterozygosity was not observed.

Conclusion

This study observed absence of CCR5-Δ32 deletion gene among the studied subjects in Calabar, implying lack of genetic advantage in HIV infection and possible rapid progression towards AIDS if other precautions are not checked.
Literature
1.
go back to reference Asemota EA, Okafor IM, Okoroiwu HU, Ekong ER, Anyanwu SO, Effiong EE, et al. Zinc, copper, CD4 T – cell count and some hematological parameters of HIV – infected subjects in southern Nigeria. Integr Med Res. 2018;7:53–60.CrossRef Asemota EA, Okafor IM, Okoroiwu HU, Ekong ER, Anyanwu SO, Effiong EE, et al. Zinc, copper, CD4 T – cell count and some hematological parameters of HIV – infected subjects in southern Nigeria. Integr Med Res. 2018;7:53–60.CrossRef
3.
go back to reference Okoroiwu HU, Okafor IM, Asemota EA, Okpokam DC. Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation. BMC Public Health. 2018;18:645.CrossRef Okoroiwu HU, Okafor IM, Asemota EA, Okpokam DC. Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation. BMC Public Health. 2018;18:645.CrossRef
4.
go back to reference Coco-Bassey SB, Asemota EA, Okoroiwu HU, Etura JE, Efiong EE, Inyang IJ, et al. Glutathione, glutathione peroxidase and some hematological parameters of HIV-seropositive subjects attending clinic in University of Calabar Teaching Hospital, Calabar, Nigeria. BMC Infect Dis. 2019;19:944.CrossRef Coco-Bassey SB, Asemota EA, Okoroiwu HU, Etura JE, Efiong EE, Inyang IJ, et al. Glutathione, glutathione peroxidase and some hematological parameters of HIV-seropositive subjects attending clinic in University of Calabar Teaching Hospital, Calabar, Nigeria. BMC Infect Dis. 2019;19:944.CrossRef
5.
go back to reference Joint United Nations Programme on HIV and AIDs (UNAIDS). The Gap report: children and pregnant women living with HIV. Geneva: UNAIDS; 2014. Joint United Nations Programme on HIV and AIDs (UNAIDS). The Gap report: children and pregnant women living with HIV. Geneva: UNAIDS; 2014.
7.
go back to reference Joint United Nations Programme on HIV and AIDs (UNAIDS). Country fast sheets; South Africa. 2017. Available at: www.unaids.org/en/regionscountries/southafrica. Accessed 26 May 2019. Joint United Nations Programme on HIV and AIDs (UNAIDS). Country fast sheets; South Africa. 2017. Available at: www.unaids.org/en/regionscountries/southafrica. Accessed 26 May 2019.
8.
go back to reference Nsonwu-Anyanwu AC, Ighodalo EV, King D, Agu CE, Jeremiah S, Solomon OT, et al. Biomarken of oxidative stress in HIV seropositive individuals on highly active antiretroviral therapy. Reactive Oxygen Species. 2017;3(9):1–11. Nsonwu-Anyanwu AC, Ighodalo EV, King D, Agu CE, Jeremiah S, Solomon OT, et al. Biomarken of oxidative stress in HIV seropositive individuals on highly active antiretroviral therapy. Reactive Oxygen Species. 2017;3(9):1–11.
9.
go back to reference Roy CP, Chakrabarti S. Mutation in AIDS restriction gene affecting the HIV infection and disease progression in a high risk group from northeastern India. Med J Armed Forces India. 2016;722:111–5.CrossRef Roy CP, Chakrabarti S. Mutation in AIDS restriction gene affecting the HIV infection and disease progression in a high risk group from northeastern India. Med J Armed Forces India. 2016;722:111–5.CrossRef
10.
go back to reference Buchbinder SP, Katz MH, Hessol NA, O’Malley PM, Holmberg SD. Long-term HIV-1 infection without immunologic progression. AIDS. 1994;8:1123–8.CrossRef Buchbinder SP, Katz MH, Hessol NA, O’Malley PM, Holmberg SD. Long-term HIV-1 infection without immunologic progression. AIDS. 1994;8:1123–8.CrossRef
11.
go back to reference Winkler C, Ping AN, Stephen J, Brien O. Patterns of ethnic diversity among the genes that influence AIDS. Hum Mol Gent. 2004;13(1):R1–R19.CrossRef Winkler C, Ping AN, Stephen J, Brien O. Patterns of ethnic diversity among the genes that influence AIDS. Hum Mol Gent. 2004;13(1):R1–R19.CrossRef
12.
go back to reference Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 1996;382:722–5.CrossRef Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 1996;382:722–5.CrossRef
13.
go back to reference O’Brien SJ, Nelson GW. Human genes that limit AIDS. Nat Genet. 2004;36:565–74.CrossRef O’Brien SJ, Nelson GW. Human genes that limit AIDS. Nat Genet. 2004;36:565–74.CrossRef
14.
go back to reference Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply – exposed individuals to HIV-1 infection. Cell. 1996;86:367–717.CrossRef Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply – exposed individuals to HIV-1 infection. Cell. 1996;86:367–717.CrossRef
15.
go back to reference Solloch UV, Lang K, Lang V, Bohne I, Shmidt AH. Frequencies of gene variant CCR5-∆32 in 87 countries based on next generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centres. Hum Immunol. 2017;78:710–7.CrossRef Solloch UV, Lang K, Lang V, Bohne I, Shmidt AH. Frequencies of gene variant CCR5-32 in 87 countries based on next generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centres. Hum Immunol. 2017;78:710–7.CrossRef
16.
go back to reference Wu L, Paxton WA, Kassam N, Ruffin N, Rottman JB, Sullivan N, et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med. 1997;185:1681–91.CrossRef Wu L, Paxton WA, Kassam N, Ruffin N, Rottman JB, Sullivan N, et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med. 1997;185:1681–91.CrossRef
17.
go back to reference Barmania F, Potgiefer M, Pepper MS. Mutation in C-C chemoreceptor type 5 (CCR5) in south African individuals. Int J Infect Dis. 2013;17:e1148–53.CrossRef Barmania F, Potgiefer M, Pepper MS. Mutation in C-C chemoreceptor type 5 (CCR5) in south African individuals. Int J Infect Dis. 2013;17:e1148–53.CrossRef
18.
go back to reference Connor RI, Sheridan KE, Ceradini S, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J Exp Med. 1997;185:621–8.CrossRef Connor RI, Sheridan KE, Ceradini S, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J Exp Med. 1997;185:621–8.CrossRef
19.
go back to reference Dragic T, Litwin V, Allaway G, Martin SR, Huang Y, Nagashima KA, et al. HIV-1 entry into CD4+ cells in mediated by the chemokine receptor CCR5. Nature. 1996;381:667–73.CrossRef Dragic T, Litwin V, Allaway G, Martin SR, Huang Y, Nagashima KA, et al. HIV-1 entry into CD4+ cells in mediated by the chemokine receptor CCR5. Nature. 1996;381:667–73.CrossRef
20.
go back to reference Deng H, Lin R, Ellmeier W, Choe S, Unutrnaz D, Burkhart M, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 1996;381:661–6.CrossRef Deng H, Lin R, Ellmeier W, Choe S, Unutrnaz D, Burkhart M, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 1996;381:661–6.CrossRef
21.
go back to reference Feng Y, Broder CC, Kennedy PI, Berger EA. HIV-1 entry co-factor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 1996;872:877. Feng Y, Broder CC, Kennedy PI, Berger EA. HIV-1 entry co-factor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 1996;872:877.
22.
go back to reference Khorramdelazad H, Bagheri V, Hassanshahi G, Zeinali M, Vakilian A. New insight into the role of stromal cell-derived factor 1 (SDF-1/CXCL12) in the pathophysiology of multiple schlerosis. Khorramdelazad H, Bagheri V, Hassanshahi G, Zeinali M, Vakilian A. New insight into the role of stromal cell-derived factor 1 (SDF-1/CXCL12) in the pathophysiology of multiple schlerosis.
23.
go back to reference Karimbadad MN, Falahati-Pour SK, Hassanshabi G. Significant role(s) of CXCL12 and SDF-1 31A genetic variant in the pathophysiology of multiple sclerosis. Neuroimmunomodulation. 2016;23:197–208.CrossRef Karimbadad MN, Falahati-Pour SK, Hassanshabi G. Significant role(s) of CXCL12 and SDF-1 31A genetic variant in the pathophysiology of multiple sclerosis. Neuroimmunomodulation. 2016;23:197–208.CrossRef
24.
go back to reference Michael NI, Nelson JA, Kewal Ramani VN, Chang G, O’Brien SJ, Mascola JR, et al. Exclusive and persistent use of the entry co-rector CxCR4 by human immunodeficiency virus type 1 form a subject homozygous for CCR5 delta 32. J Virol. 1998;72:6040–7.CrossRef Michael NI, Nelson JA, Kewal Ramani VN, Chang G, O’Brien SJ, Mascola JR, et al. Exclusive and persistent use of the entry co-rector CxCR4 by human immunodeficiency virus type 1 form a subject homozygous for CCR5 delta 32. J Virol. 1998;72:6040–7.CrossRef
25.
go back to reference Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB. Global distribution of the CCR5 gene 32 base pair deletion. Nat Genet. 1997;16:100–3.CrossRef Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB. Global distribution of the CCR5 gene 32 base pair deletion. Nat Genet. 1997;16:100–3.CrossRef
26.
go back to reference Nwabueze BO. A constitutional history of Nigeria. United Kingdom: C. Hurst and Co. LTD.; 1982. Nwabueze BO. A constitutional history of Nigeria. United Kingdom: C. Hurst and Co. LTD.; 1982.
27.
go back to reference Wikipedia, the free encyclopedia. Geography of Cross River State. Available at: https//en.wikipedia.org/wiki/Cross_River_State . Accessed 27 May 2019. Wikipedia, the free encyclopedia. Geography of Cross River State. Available at: https//en.wikipedia.org/wiki/Cross_River_State . Accessed 27 May 2019.
28.
go back to reference National Bureau of Statistics. Annual abstract of statistics 2011. NBS Federal Republic of Nigeria 2011. National Bureau of Statistics. Annual abstract of statistics 2011. NBS Federal Republic of Nigeria 2011.
29.
go back to reference Okoroiwu HU, Asemota EA. Blood donors deferral prevalence and causes in a tertiary health care hospital, southern Nigeria. BMC Health Serv Res. 2019;19:510.CrossRef Okoroiwu HU, Asemota EA. Blood donors deferral prevalence and causes in a tertiary health care hospital, southern Nigeria. BMC Health Serv Res. 2019;19:510.CrossRef
30.
go back to reference Kenneth OZ, Opuata S, Tatfeng YM TCA, Zaccheaus AJ. Null single nucleotide polymorphism in Cysteine – cysteine chemokine receptor 5 genes among Ijaw Etnic Population of Nigeria. Open J Blood Dis. 2016;2(3):1–6. Kenneth OZ, Opuata S, Tatfeng YM TCA, Zaccheaus AJ. Null single nucleotide polymorphism in Cysteine – cysteine chemokine receptor 5 genes among Ijaw Etnic Population of Nigeria. Open J Blood Dis. 2016;2(3):1–6.
31.
go back to reference Novembre J, Galvani AP, Slatkin M. The geographic spread of the CCR5∆32 HIV-resistance allele. Plos Biol. 2005;3(11):e339.CrossRef Novembre J, Galvani AP, Slatkin M. The geographic spread of the CCR532 HIV-resistance allele. Plos Biol. 2005;3(11):e339.CrossRef
32.
go back to reference Salem AH, Batzer MA. Distribution of the HIV resistance CCR5-delta 32 allele among Egytians and Syrians. Mutat Res. 2007;616:175–80.CrossRef Salem AH, Batzer MA. Distribution of the HIV resistance CCR5-delta 32 allele among Egytians and Syrians. Mutat Res. 2007;616:175–80.CrossRef
33.
go back to reference Su B, Sun G, Lu D, Xiao J, Hu F, Chakraborty R, Deka R, Jin L. Distribution of three HIV-1 resistance – conferring Polymorphisms (SDF1–3’A, CCR2–641 and CCR5 -∆32) in global populations. Eur J Hum Genet. 2000;8:975–9.CrossRef Su B, Sun G, Lu D, Xiao J, Hu F, Chakraborty R, Deka R, Jin L. Distribution of three HIV-1 resistance – conferring Polymorphisms (SDF1–3’A, CCR2–641 and CCR5 -32) in global populations. Eur J Hum Genet. 2000;8:975–9.CrossRef
34.
go back to reference Galvani AP, November J. The evolutionary history of the CCR5-Delta 32 HIV-resistance mutation. Microbes Infect. 2005;7:302–9.CrossRef Galvani AP, November J. The evolutionary history of the CCR5-Delta 32 HIV-resistance mutation. Microbes Infect. 2005;7:302–9.CrossRef
35.
go back to reference Picton ACP, Shalekoff S, Paximadis M, Tiemessen CT. Marked differences in CCR5 expression and activation levels in two South African Populations. Immunology. 2012;136:397–407.CrossRef Picton ACP, Shalekoff S, Paximadis M, Tiemessen CT. Marked differences in CCR5 expression and activation levels in two South African Populations. Immunology. 2012;136:397–407.CrossRef
Metadata
Title
Cysteine-cysteine chemokine receptor 5 (CCR5) profile of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria
Authors
Ekerette Friday Ekere
Monday F. Useh
Henshaw Uchechi Okoroiwu
Tatfeng Youtchou Mirabeau
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4737-1

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue